MyFinsight
Home
Blog
About
Cash and cash
equivalents
$79,903K
(110.09%↑ Y/Y)
Inventory, net
$6,985K
(-36.88%↓ Y/Y)
Prepaid expenses and
other current assets
$5,569K
(148.95%↑ Y/Y)
Accounts receivable
$330K
(-16.24%↓ Y/Y)
Total current assets
$92,787K
(79.37%↑ Y/Y)
Finance lease
right-of-use assets, net
$28,249K
(95.59%↑ Y/Y)
Property and equipment,
net
$16,170K
(-23.69%↓ Y/Y)
Other long-term
assets
$672K
(-45.01%↓ Y/Y)
Restricted cash
$209K
(-99.58%↓ Y/Y)
Total assets
$138,087K
(-0.51%↓ Y/Y)
Total liabilities and
stockholders' equity
$138,087K
(-0.51%↓ Y/Y)
Total liabilities
$106,826K
(-20.72%↓ Y/Y)
Total stockholders'
equity
$31,261K
(671.50%↑ Y/Y)
Accumulated deficit
-$781,269K
(-14.13%↓ Y/Y)
Long-term debt
$36,324K
Finance lease
obligation, net of current...
$28,338K
(135.56%↑ Y/Y)
Common stock warrant
liabilities
$15,651K
(259.13%↑ Y/Y)
Total current
liabilities
$14,948K
(-29.11%↓ Y/Y)
Contingent earnout
liability
$9,478K
(-64.50%↓ Y/Y)
Other long-term
liabilities
$2,087K
(112.09%↑ Y/Y)
Additional paid-in capital
$812,502K
(18.00%↑ Y/Y)
Common stock, 0.0001
par value...
$28K
(75.00%↑ Y/Y)
Accrued expenses
$9,273K
(0.95%↑ Y/Y)
Accounts payable
$4,157K
(-37.29%↓ Y/Y)
Finance lease
obligation, current portion
$1,518K
(-50.92%↓ Y/Y)
Back
Back
Balance Sheet
Humacyte, Inc. (HUMA)
Humacyte, Inc. (HUMA)
source: myfinsight.com